Healthcare
April 13, 2018 / 1:08 PM / 8 months ago

BRIEF-Guangzhou Baiyunshan Pharmaceutical Updates On Acquisition

1 Min Read

April 13 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings:

* RECEIVED LETTER OF NO FURTHER REVIEW FROM ANTI-MONOPOLY BUREAU OF MINISTRY OF COMMERCE OF PRC

* PROPOSED ACQUISITION NOT SUBJECT TO FURTHER REVIEW, CO MAY PROCEED WITH ACQUISITION FROM APRIL 9 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.